InvestorsHub Logo
Followers 16
Posts 1609
Boards Moderated 0
Alias Born 04/20/2011

Re: John_Langston post# 121828

Monday, 08/18/2014 10:14:16 PM

Monday, August 18, 2014 10:14:16 PM

Post# of 401631
As an investor in Elite since '04 I can tell you my personal opinion is that Elite will never go that low ever again. What is happening right now is very special and what many of us long-term investors have been waiting years for.

It's the execution of well thought out plan that now hinges on positive data coming from study results over the next two months. If you think that data will not be positive then so be it. But as a physician who has followed this company for 10 years I believe this delivery system will be best practice whether it is Elite or any other pharma company that produces it. It just so happens that Elite currently has the patents and the financial ability to move forward.

Elite's management knows if they validate the data and get one ART product submitted they are a target for numerous pharma companies who will be vying to buy them out. By doing the work on ELI200 you validate to an acquiring company that your tech is proven and they are buying the legal protection/patents and an infallible approval process via the FDA that will allow the acquiring company to produce/license 10-15 ART products.

I think Elite gets bought out between submission and approval by a company that doesn't want to get into a multi billion dollar bidding war.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News